InsidersTradesSigma
申报总数
公司
▲ 买入（4 笔）
▼ 卖出（0 笔）
内部人交易记录
首席财务官已披露买入
4
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Discover the detailed record of transactions filed by Brown Scott B., 首席财务官. Officer active across 1 company, notably Tracon Pharmaceuticals, Inc.. In total, 5 disclosures have been recorded. Split: 4 buys · 0 sell. Total volume traded: €16k. History available since 13 August 2021. The latest transaction was disclosed on 20 April 2023 (Attribution). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Brown Scott B.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报5 总计
3,500 股@ US$0.13772.3% 占其流量Common StockSEC:0001415889-24-007849:0
3,500 股@ US$1.4925.6% 占其流量Common StockSEC:0001209191-23-000001:0
标准退出：2023年3月29日 (T+90)
2,500 股@ US$2.01526.0% 占其流量Common StockSEC:0001209191-22-049886:0
标准退出：2022年12月11日 (T+90)
1,000 股@ US$2.8215.9% 占其流量Common StockSEC:0001209191-22-021567:0
标准退出：2022年6月27日 (T+90)
1,000 股@ US$3.694619.7% 占其流量Common StockSEC:0001209191-21-051913:0
标准退出：2021年11月11日 (T+90)
5 条申报中的 5 条
About Brown Scott B.
Scott B. Brown is Chief Financial Officer at Tracon Pharmaceuticals, Inc. He oversees the financial management of the company, including financial planning and reporting. His role is essential for ensuring the financial health and growth of the company.
